+25.5%
GSK vs RCAT
+1.5%
+24.0%
-18.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RCAT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | +3.9% | -6.6% | -2.6% |
| 7D | -4.2% | +5.4% | -9.6% | -4.1% |
| 30D | -7.5% | -5.6% | -1.9% | -7.6% |
| 3M | -3.3% | -30.2% | +26.9% | -3.8% |
| 6M | -9.3% | -43.4% | +34.1% | -10.0% |
| YTD | +1.6% | +9.6% | -8.0% | +1.5% |
| 1Y | +25.5% | -2.0% | +27.5% | +24.5% |
| All | +25.5% | +1.5% | +24.0% | +24.5% |
Cumulative growth
Daily Returns
Daily percentage return beside RCAT.
Daily Out/Under-Performance
Portfolio return minus RCAT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RCAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RCAT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling